Q3 2024 Health Catalyst Inc Earnings Call Transcript
Key Points
- Health Catalyst Inc (HCAT) reported total revenue of $76.4 million and adjusted EBITDA of $7.3 million for Q3 2024, both exceeding the midpoint of previous guidance.
- The company anticipates 2024 revenue to be between $305 million and $311 million, with adjusted EBITDA expectations raised to between $25 million and $27 million.
- Health Catalyst Inc (HCAT) has seen strong demand for its Ignite platform, with successful client migrations and new client acquisitions contributing to growth.
- The company has been recognized as one of the best workplaces in healthcare by Fortune and received other accolades, highlighting its positive work environment and industry reputation.
- Health Catalyst Inc (HCAT) has a robust pipeline and expects to return to double-digit revenue growth in 2025, driven by new client additions, existing client expansions, and strategic acquisitions.
- The company faces challenges with longer implementation timelines for international and health information exchange contracts, which could delay revenue recognition.
- There are ongoing costs associated with the deployment of the Ninja Universe platform and migration from DOS to Ignite, impacting technology gross margins.
- Professional services revenue remained flat year-over-year, and there are pressures on professional services gross margins due to incremental resourcing and seasonal expenses.
- Health Catalyst Inc (HCAT) is experiencing lower bookings in certain areas due to a strategic focus on higher-margin solutions, which may impact near-term revenue.
- The company is still learning and adjusting cost structures in new areas like ambulatory operations within its tech-enabled managed services (TEMS), which could affect profitability.
Welcome to the Health Catalyst third quarter, 2024 earnings conference call.
(Operator Instructions).
I would now like to turn the call over to Jack Knight Vice President of Investor Relations.
Good afternoon and welcome to Health Catalyst's earnings conference call for the third quarter of 2024 which ended on September 30, 2024. My name is Jack Knight. I'm the Vice President of Investor Relations for Health Catalyst.
And with me on the call is Dan Burton, our Chief Executive Officer, Jason Alger, our Chief Financial Officer, and Dan LeSueur, our Chief Operating Officer, a complete disclosure of our results can be found in our press release issued today as well as in our related form 8-K furnished to the SEC, both of which are available on the investor relations section of our website at ir.healthcatalyst.com.
As a reminder, today's call is being recorded and a replay will be available following the conclusion of the call.
During today's call
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
